T1 Gene 1056 1067 genetically
T2 Condition 1076 1092 tumor xenografts
T4 Protein 925 929 PARP
T5 Level 648 654  cells
T6 Biomarker 1400 1415 oncometabolites
T7 Level 1004 1040 primary patient-derived glioma cells
T8 Biomarker 20 23 2HG
T9 Level 852 858  cells
T11 Level 903 909 mutant
T12 Level 733 739 mutant
T13 Level 642 648 mutant
T14 Protein 578 590  polymerase 
T15 Condition 312 316 IDH1
T16 Protein 1425 1428 DNA
T17 Level 834 850 2HG enantiomers 
T18 Condition 740 744 IDH1
T19 Gene 1213 1223 mutant IDH
T20 Protein 700 725 small-molecule inhibitors
T21 Protein 150 166 Î±-ketoglutarate 
T22 Gene 733 743 mutant IDH
T23 Condition 428 432 IDH1
T24 Protein 876 886 2 proteins
T25 Condition 322 336 IDH2 mutations
T26 Gene 284 310 isocitrate dehydrogenase 1
T27 Condition 433 444 2 mutations
T28 Protein 591 595 PARP
T29 Gene 1056 1063 genetic
T31 Level 1034 1040  cells
T32 Gene 903 913 mutant IDH
T33 Protein 1323 1327 PARP
T34 Condition 1076 1081 tumor
T35 Biomarker 1290 1293 2HG
T36 Biomarker 1257 1260 2HG
T38 Gene 733 751 mutant IDH1 enzyme
T39 Level 638 654 IDH mutant cells
T40 Biomarker 1400 1414 oncometabolite
T41 Biomarker 834 837 2HG
T42 Disease 404 411 hypoxia
T43 Biomarker 56 59 2HG
T44 Condition 504 509 tumor
T45 Condition 910 914 IDH1
T46 Condition 871 875 IDH1
T47 Condition 100 105 tumor
T48 Gene 1441 1448 genetic
T49 Level 1213 1219 mutant
T50 Biomarker 1290 1317 2HG-dependent HR deficiency
T51 Biomarker 213 227 oncometabolite
